Connaughton Bernadette sold HALO
January 5, 2026 · Form 4 insider transaction
Connaughton Bernadette sold 2,000 shares of Halozyme Therapeutics, Inc. at $70.25 per share, a transaction worth $140.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$70.25
Total value
$140.5K
InsiderConnaughton Bernadette
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after40,123
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.